Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
12/2013
12/04/2013CN103420877A Selective hydroxamate-based MMP inhibitors
12/04/2013CN102702086B Method for preparing 2, 3-dichloro-5-trichloromethylpyridine by using residues of DCTC (2, 3-dichloro-5-trichloromethylpyridine) from short steaming process
12/04/2013CN102702084B Single\two-photon calcium ion fluorescent probe compound and preparation and application thereof
12/04/2013CN102532010B Preparation method of 2-chloro-3-aminopyridine
12/04/2013CN102304086B Heterocyclic inhibitors of MEK and methods of use thereof
12/04/2013CN102160233B Dye-sensitized photovoltaic device
12/04/2013CN101827811B Histone deacetylase inhibitor, preparation and use thereof
12/04/2013CN101622231B 2,2,2-tri-substituted acetamide derivatives as glucokinase activators, their process and pharmaceutical application
12/04/2013CN101466665B Compositions useful as inhibitors of voltage-gated sodium channels
12/03/2013US8598365 Herbicides
12/03/2013US8598364 Oligomer-protease inhibitor conjugates
12/03/2013US8598363 Process for manufacturing 2-[(3,5-difluoro-3′-methoxy-1,1′biphenyl-4-yl)amino]nicotinic acid
12/03/2013US8598345 Substituted heteroarylamide analogs as mGluR5 negative allosteric modulators and methods of making and using the same
12/03/2013US8598210 Prolyl hydroxylase inhibitors and methods of use
12/03/2013US8598209 P2X3, receptor antagonists for treatment of pain
12/03/2013US8598206 Trypsin-like serine protease inhibitors, and their preparation and use
12/03/2013US8598148 Synthesis of tetracyclines and analogues thereof
12/03/2013US8598086 3-halo-(arly)-4-iminotetrahydropicolinates and their use as herbicides
12/03/2013CA2599411C Enzyme inhibitors
12/03/2013CA2570987C Novel alkynyl derivatives as modulators of metabotropic glutamate receptors
12/03/2013CA2530302C Novel aminobenzophenone compounds
12/03/2013CA2489590C Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
11/2013
11/28/2013WO2013177224A1 N-substituted benzamides and their use in the treatment of pain
11/28/2013WO2013175506A2 Process for sorafenib tosylate polymorph iii
11/28/2013WO2013175483A1 Process for preparing crystalline sorafenib tosylate
11/28/2013WO2013175397A1 New process for the preparation of 2-cyclopentyl-6-methoxy-isonicotinic acid
11/28/2013WO2013174947A1 Inhibitors of the activity of complex (iii) of the mitochondrial electron transport chain and use thereof
11/28/2013WO2013174207A1 Protein tyrosine phosphatase inhibitor, preparation method and uses thereof
11/28/2013WO2013111158A3 Process for the preparation of dpp-iv inhibitor
11/28/2013US20130317066 Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities
11/28/2013US20130317027 Compounds and therapeutic uses thereof
11/28/2013US20130317020 Pyridyl Derivatives as CFTR Modulators
11/28/2013US20130317001 N-substituted benzamides and methods of use thereof
11/28/2013US20130317000 N-substituted benzamides and methods of use thereof
11/28/2013US20130316907 Process for preparation of herbicidal salts
11/28/2013DE4428766B4 Benzolderivate und flüssigkristallines Medium Benzene derivatives and liquid crystalline medium
11/28/2013DE4411806B4 Flüssigkristallines Medium Liquid-crystalline medium
11/27/2013EP2666767A1 Therapeutic agent for TRPV1-mediated disease
11/27/2013EP2666766A1 Novel E,E-diene compounds and their use as medicaments and cosmetics
11/27/2013EP2666481A2 Method of regulating phosphorylation of sr protein and antiviral agents comprising sr protein activity regulator as the active ingredient
11/27/2013EP2665711A1 Picolinamide inhibitors of kinases
11/27/2013EP2665710A1 6-(2-aminophenyl)picolinates and their use as herbicides
11/27/2013EP2665709A1 Diarylacetylene hydrazide containing tyrosine kinase inhibitors
11/27/2013CN103415507A 3-amino-pyridines as GPBAR1 agonists
11/27/2013CN103415288A Internal parasiticide
11/27/2013CN103408489A Preparation method of 3-cyanopyridine oxynitride
11/27/2013CN103408488A Optimal synthetic method of sorafenib
11/27/2013CN103408487A Refining method of gimeracil
11/27/2013CN103408486A Preparation method of 4-pyridinemethanol
11/27/2013CN103408485A 4'-(3-methoxyl-4-hydroxylphenyl)-2,2': 6',2'-terpyridyl and preparation method thereof
11/27/2013CN103408484A Tetra-alkyl periflanthene derivatives and applications thereof
11/27/2013CN103408433A Method for synthesizing propargylamine compounds
11/27/2013CN103404518A Target for preventing and killing weed-crofton weed and application of target
11/27/2013CN102731373B Preparation method of intermediate of antitumor drug GDC-0449 (vismodegib)
11/27/2013CN102421754B Acrylamide derivative and use thereof in manufacture of medicament
11/27/2013CN102249988B Method for recovering pyridine
11/27/2013CN101918362B 吡啶衍生物 Pyridine derivatives
11/27/2013CN101830763B Application of nickel catalyst in suzuki-miyaura coupling reaction
11/26/2013US8592498 Method for producing organic compound and organic compound obtained by the method
11/26/2013US8592419 Ceramides and apoptosis-signaling ligand
11/26/2013CA2585615C Dicarboxamide derivatives and their use as factor xa inhibitors
11/21/2013WO2013173746A2 Use of fluorinated derivatives of 4-aminopyridine in therapeutics and medical imaging
11/21/2013WO2013172225A1 Method for manufacturing transparent electrode
11/21/2013WO2013171641A1 Compounds and compositions for inhibiting the activity of abl1, abl2 and bcr-abl1
11/21/2013WO2013171639A1 Benzamide derivatives for inhibiting the activity of abl1, abl2 and bcr-abl1
11/21/2013WO2013171316A1 Pyridine derivatives and their use in the treatment of conditions associated with pathological thrombus formation
11/21/2013WO2013171307A1 N-methyl-4-benzylcarbamidopyridinium chloride and a process for its preparation
11/21/2013WO2013170901A1 N-methyl-4-benzylcarbamidopyridinium chloride and a process for its preparation
11/21/2013US20130310564 Processes and Intermediates for Preparing Fused Heterocyclic Kinase Inhibitors
11/21/2013US20130310425 Novel polymorph forms of (2s)-(4e)-n-methyl-5-[3-(5-isopropoxypyridin)yl]-4-penten-2-amine
11/21/2013US20130310399 Chemical compounds
11/21/2013US20130310384 Sulfonamide-Containing Compounds
11/21/2013US20130310378 4-(4-pyridinyl)-benzamides and their use as rock activity modulators
11/21/2013US20130310347 Multi-modality molecular imaging high-throughput assay for identifying heat shock protein 90 (hsp90) inhibitors
11/21/2013US20130310320 Boronic ester and acid compounds, synthesis and uses
11/20/2013EP2468717B1 Heterocyclic Amide Compounds Useful as Kinase Inhibitors
11/20/2013EP2403832B1 N-(hetero)aryl,2-(hetero)aryl-substituted acetamides for use as wnt signaling modulators
11/20/2013EP2271621B1 Pyridyl derivatives as cftr modulators
11/20/2013EP2253610B1 Method for manufacturing of enaminocarbonyl-compounds and their use in preparing 4-aminobut-2-enolids
11/20/2013EP2220029B1 Benzamide compounds and their use as prostaglandin E4 receptor agonists
11/20/2013EP2123627B1 Process for producing aromatic amine having aralkyloxy or heteroaralkyloxy group
11/20/2013EP1827501B2 Stabilized polymeric thiol reagents
11/20/2013EP1802579B1 Derivatives of 3-arylaminopyridine
11/20/2013CN103402984A Novel kinase inhibitors
11/20/2013CN103402983A (Pyridin-4-yl)benzylamides as allosteric modulators of alpha 7 NACHR
11/20/2013CN103402982A Synthesis of 2-carboxamide cycloamino urea derivatives
11/20/2013CN103402981A Compound containing substituted triphenyle ring structure, and organic electroluminescent element
11/20/2013CN103402949A A new palladium catalyst, method for its preparation and its use
11/20/2013CN103396789A Triphenylamine two-photon fluorescence probe compound and preparation method and application thereof
11/20/2013CN103396402A Substituted aminoindanes and analogs thereof, and pharmaceutical use thereof
11/20/2013CN103396363A 1,3-dimethylbutyl carboxanilides for controlling undesirable micro-organisms
11/20/2013CN103396359A Iminipyridine derivatives and uses thereof as microbiocides
11/20/2013CN103396358A Method for synthesizing 4-dimethylamino pyridine and analogues thereof
11/20/2013CN103396357A Preparation method of 2,3-difluoro-5-chloropyridine
11/20/2013CN103396356A Spirofluorene copper pyridine micro-nano particle and preparation method thereof
11/20/2013CN103396355A Compound using tripyridylbenzene as core as well as preparation method and application thereof
11/20/2013CN103396349A Acyl thiourea compound containing 1-methyl cyclohexyl as well as preparation method and application thereof
11/20/2013CN103396329A Method for preparing beta-perfluoroalkyl enaminoketone
11/20/2013CN103396319A Method for preparing nitrocompounds from nitrogen suboxides
11/20/2013CN103396315A Method for preparing nitrocompounds from nitrogen suboxides
1 ... 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 ... 633